RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 133 filers reported holding RECURSION PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.76 and the average weighting 2.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,085,514 | +17.9% | 664,773 | +15.1% | 0.00% | 0.0% |
Q2 2023 | $4,313,515 | +20.9% | 577,445 | +7.9% | 0.00% | 0.0% |
Q1 2023 | $3,569,297 | -20.6% | 535,127 | -8.2% | 0.00% | 0.0% |
Q4 2022 | $4,494,945 | +18.0% | 583,002 | +62.8% | 0.00% | 0.0% |
Q3 2022 | $3,809,000 | +138.7% | 358,066 | +82.6% | 0.00% | – |
Q2 2022 | $1,596,000 | +6.5% | 196,067 | -6.4% | 0.00% | – |
Q1 2022 | $1,499,000 | -29.2% | 209,409 | +69.4% | 0.00% | – |
Q4 2021 | $2,117,000 | +393.5% | 123,586 | +562.1% | 0.00% | – |
Q3 2021 | $429,000 | +6.7% | 18,667 | +69.5% | 0.00% | – |
Q2 2021 | $402,000 | – | 11,013 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Data Collective IV GP, LLC | 5,941,120 | $45,806,035 | 48.11% |
Kinnevik AB (publ) | 7,653,061 | $59,005,100 | 33.28% |
MV Management XI, L.L.C. | 1,971,908 | $15,203,411 | 26.45% |
MIC Capital Management UK LLP | 8,451,758 | $65,163,057 | 12.86% |
ArchPoint Investors | 1,114,626 | $8,593,766 | 4.07% |
HARVARD MANAGEMENT CO INC | 1,509,254 | $11,636,348 | 1.44% |
PLATINUM INVESTMENT MANAGEMENT LTD | 2,710,339 | $20,896,714 | 0.80% |
Duquesne Family Office | 1,385,950 | $10,685,675 | 0.53% |
ALLEN OPERATIONS LLC | 217,657 | $1,678,135 | 0.45% |
Artal Group S.A. | 960,204 | $7,403 | 0.41% |